Literature DB >> 11381862

Cutaneous malignancy in albinism.

P K Perry1, N B Silverberg.   

Abstract

Albinism is a disorder of hypopigmentation affecting the skin, appendages, and eyes. Ultraviolet light-induced cutaneous tumors are common in patients with albinism due to reduced or absent protection from melanin. Squamous cell carcinoma (SCC) is the number one skin tumor seen in patients who are albinos. Although nonmelanomatous skin cancers are more common in patients with albinism, dysplastic nevus and melanoma present a greater diagnostic challenge in this group because of their hypopigmented appearance. We report 2 cases of cutaneous malignancies in patients who had oculocutaneous albinism (OCA). The first case involves a 45-year-old man with OCA type 2 (OCA2) who developed a large SCC of the neck. The second case involves a 24-year-old man with Hermansky-Pudiak syndrome (HPS) who developed amelanotic melanoma. In both cases, hypopigmentation of the lesions contributed to a delay in diagnosis. We review the clinical, diagnostic, and therapeutic concerns for patients with albinism who have cutaneous malignancies.

Entities:  

Mesh:

Year:  2001        PMID: 11381862

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  10 in total

Review 1.  Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis.

Authors:  Meg R Gerstenblith; Jianxin Shi; Maria Teresa Landi
Journal:  Pigment Cell Melanoma Res       Date:  2010-07-16       Impact factor: 4.693

2.  Characterizing melanoma in the setting of oculocutaneous albinism: an analysis of the literature.

Authors:  S Ravichandran; P Funchain; J Arbesman
Journal:  Arch Dermatol Res       Date:  2022-07-18       Impact factor: 3.033

Review 3.  Was skin cancer a selective force for black pigmentation in early hominin evolution?

Authors:  Mel Greaves
Journal:  Proc Biol Sci       Date:  2014-02-26       Impact factor: 5.349

4.  Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin.

Authors:  Seiji Takeuchi; Wengeng Zhang; Kazumasa Wakamatsu; Shosuke Ito; Vincent J Hearing; Kenneth H Kraemer; Douglas E Brash
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

5.  A molecular systems approach to modelling human skin pigmentation: identifying underlying pathways and critical components.

Authors:  Arathi Raghunath; Awanti Sambarey; Neha Sharma; Usha Mahadevan; Nagasuma Chandra
Journal:  BMC Res Notes       Date:  2015-04-29

6.  Proposal for management and dermoscopy follow-up of nevi in patients affected by oculocutaneous albinism type Ia.

Authors:  Rosario Peralta; Emilia Cohen Sabban; Paula Friedman; Carolina Marcucci; Luis A Bollea Garlatti; Gastón Galimberti; Horacio Cabo
Journal:  Dermatol Pract Concept       Date:  2017-01-31

Review 7.  Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors.

Authors:  Carolina Reato Marçon; Marcus Maia
Journal:  An Bras Dermatol       Date:  2019-09-30       Impact factor: 1.896

8.  Amelanotic melanoma in a patient with Hermansky-Pudlak syndrome.

Authors:  Ryan Fan; Margaret S Johnston; Michael F Gowen; William Damsky; Ian Odell; James Clune; Matthew D Vesely
Journal:  JAAD Case Rep       Date:  2022-07-06

9.  Dermatologic manifestations in patients with the Hermansky-Pudlak syndrome types 1 and 3.

Authors:  Gabriel Santos Malave; Natalio J Izquierdo; Nestor P Sanchez
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

10.  Cutaneous Cancers in Nigerian Albinos: A Review of 22 Cases.

Authors:  Oluwafemi Olasupo Awe; Terence Akhator Azeke
Journal:  Niger J Surg       Date:  2018 Jan-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.